401 related articles for article (PubMed ID: 20019332)
1. Effects of mechanical stress and carvedilol in lamin A/C-deficient dilated cardiomyopathy.
Chandar S; Yeo LS; Leimena C; Tan JC; Xiao XH; Nikolova-Krstevski V; Yasuoka Y; Gardiner-Garden M; Wu J; Kesteven S; Karlsdotter L; Natarajan S; Carlton A; Rainer S; Feneley MP; Fatkin D
Circ Res; 2010 Feb; 106(3):573-82. PubMed ID: 20019332
[TBL] [Abstract][Full Text] [Related]
2. Defects in nuclear structure and function promote dilated cardiomyopathy in lamin A/C-deficient mice.
Nikolova V; Leimena C; McMahon AC; Tan JC; Chandar S; Jogia D; Kesteven SH; Michalicek J; Otway R; Verheyen F; Rainer S; Stewart CL; Martin D; Feneley MP; Fatkin D
J Clin Invest; 2004 Feb; 113(3):357-69. PubMed ID: 14755333
[TBL] [Abstract][Full Text] [Related]
3. Nesprin-1 and actin contribute to nuclear and cytoskeletal defects in lamin A/C-deficient cardiomyopathy.
Nikolova-Krstevski V; Leimena C; Xiao XH; Kesteven S; Tan JC; Yeo LS; Yu ZY; Zhang Q; Carlton A; Head S; Shanahan C; Feneley MP; Fatkin D
J Mol Cell Cardiol; 2011 Mar; 50(3):479-86. PubMed ID: 21156181
[TBL] [Abstract][Full Text] [Related]
4. Heterozygous LmnadelK32 mice develop dilated cardiomyopathy through a combined pathomechanism of haploinsufficiency and peptide toxicity.
Cattin ME; Bertrand AT; Schlossarek S; Le Bihan MC; Skov Jensen S; Neuber C; Crocini C; Maron S; Lainé J; Mougenot N; Varnous S; Fromes Y; Hansen A; Eschenhagen T; Decostre V; Carrier L; Bonne G
Hum Mol Genet; 2013 Aug; 22(15):3152-64. PubMed ID: 23575224
[TBL] [Abstract][Full Text] [Related]
5. Nuclear accumulation of androgen receptor in gender difference of dilated cardiomyopathy due to lamin A/C mutations.
Arimura T; Onoue K; Takahashi-Tanaka Y; Ishikawa T; Kuwahara M; Setou M; Shigenobu S; Yamaguchi K; Bertrand AT; Machida N; Takayama K; Fukusato M; Tanaka R; Somekawa S; Nakano T; Yamane Y; Kuba K; Imai Y; Saito Y; Bonne G; Kimura A
Cardiovasc Res; 2013 Aug; 99(3):382-94. PubMed ID: 23631840
[TBL] [Abstract][Full Text] [Related]
6. Lamin A/C haploinsufficiency causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction system disease.
Wolf CM; Wang L; Alcalai R; Pizard A; Burgon PG; Ahmad F; Sherwood M; Branco DM; Wakimoto H; Fishman GI; See V; Stewart CL; Conner DA; Berul CI; Seidman CE; Seidman JG
J Mol Cell Cardiol; 2008 Feb; 44(2):293-303. PubMed ID: 18182166
[TBL] [Abstract][Full Text] [Related]
7. The LMNA mutation p.Arg321Ter associated with dilated cardiomyopathy leads to reduced expression and a skewed ratio of lamin A and lamin C proteins.
Al-Saaidi R; Rasmussen TB; Palmfeldt J; Nissen PH; Beqqali A; Hansen J; Pinto YM; Boesen T; Mogensen J; Bross P
Exp Cell Res; 2013 Nov; 319(19):3010-9. PubMed ID: 24001739
[TBL] [Abstract][Full Text] [Related]
8. Expression of an LMNA-N195K variant of A-type lamins results in cardiac conduction defects and death in mice.
Mounkes LC; Kozlov SV; Rottman JN; Stewart CL
Hum Mol Genet; 2005 Aug; 14(15):2167-80. PubMed ID: 15972724
[TBL] [Abstract][Full Text] [Related]
9. Quantitative expression of the mutated lamin A/C gene in patients with cardiolaminopathy.
Narula N; Favalli V; Tarantino P; Grasso M; Pilotto A; Bellazzi R; Serio A; Gambarin FI; Charron P; Meder B; Pinto Y; Elliott PM; Mogensen J; Bolognesi M; Bollati M; Arbustini E
J Am Coll Cardiol; 2012 Nov; 60(19):1916-20. PubMed ID: 23062543
[TBL] [Abstract][Full Text] [Related]
10. DNA Damage Response/TP53 Pathway Is Activated and Contributes to the Pathogenesis of Dilated Cardiomyopathy Associated With LMNA (Lamin A/C) Mutations.
Chen SN; Lombardi R; Karmouch J; Tsai JY; Czernuszewicz G; Taylor MRG; Mestroni L; Coarfa C; Gurha P; Marian AJ
Circ Res; 2019 Mar; 124(6):856-873. PubMed ID: 30696354
[TBL] [Abstract][Full Text] [Related]
11. Mutation in lamin A/C sensitizes the myocardium to exercise-induced mechanical stress but has no effect on skeletal muscles in mouse.
Cattin ME; Ferry A; Vignaud A; Mougenot N; Jacquet A; Wahbi K; Bertrand AT; Bonne G
Neuromuscul Disord; 2016 Aug; 26(8):490-9. PubMed ID: 27287550
[TBL] [Abstract][Full Text] [Related]
12. Identification of mutational hot spots in LMNA encoding lamin A/C in patients with familial dilated cardiomyopathy.
Perrot A; Hussein S; Ruppert V; Schmidt HH; Wehnert MS; Duong NT; Posch MG; Panek A; Dietz R; Kindermann I; Böhm M; Michalewska-Wludarczyk A; Richter A; Maisch B; Pankuweit S; Ozcelik C
Basic Res Cardiol; 2009 Jan; 104(1):90-9. PubMed ID: 18795223
[TBL] [Abstract][Full Text] [Related]
13. In vivo and in vitro examination of the functional significances of novel lamin gene mutations in heart failure patients.
Sylvius N; Bilinska ZT; Veinot JP; Fidzianska A; Bolongo PM; Poon S; McKeown P; Davies RA; Chan KL; Tang AS; Dyack S; Grzybowski J; Ruzyllo W; McBride H; Tesson F
J Med Genet; 2005 Aug; 42(8):639-47. PubMed ID: 16061563
[TBL] [Abstract][Full Text] [Related]
14. Dilated cardiomyopathy caused by LMNA mutations. Clinical and morphological studies.
Bilińska ZT; Sylvius N; Grzybowski J; Fidziańska A; Michalak E; Walczak E; Walski M; Bieganowska K; Szymaniak E; Kuśmierczyk-Droszcz B; Lubiszewska B; Wagner T; Tesson F; Ruzyłło W
Kardiol Pol; 2006 Aug; 64(8):812-9; discussion 820-1. PubMed ID: 16981056
[TBL] [Abstract][Full Text] [Related]
15. Prolonged mechanical unloading preserves myocardial contractility but impairs relaxation in rat heart of dilated cardiomyopathy accompanied by myocardial stiffness and apoptosis.
Muranaka H; Marui A; Tsukashita M; Wang J; Nakano J; Ikeda T; Sakata R
J Thorac Cardiovasc Surg; 2010 Oct; 140(4):916-22. PubMed ID: 20381089
[TBL] [Abstract][Full Text] [Related]
16. High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics.
van Tintelen JP; Hofstra RM; Katerberg H; Rossenbacker T; Wiesfeld AC; du Marchie Sarvaas GJ; Wilde AA; van Langen IM; Nannenberg EA; van der Kooi AJ; Kraak M; van Gelder IC; van Veldhuisen DJ; Vos Y; van den Berg MP;
Am Heart J; 2007 Dec; 154(6):1130-9. PubMed ID: 18035086
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effect of {beta}-adrenoceptor blockers using a mouse model of dilated cardiomyopathy with a troponin mutation.
Zhan DY; Morimoto S; Du CK; Wang YY; Lu QW; Tanaka A; Ide T; Miwa Y; Takahashi-Yanaga F; Sasaguri T
Cardiovasc Res; 2009 Oct; 84(1):64-71. PubMed ID: 19477965
[TBL] [Abstract][Full Text] [Related]
18. Arg389Gly-beta1-adrenergic receptors determine improvement in left ventricular systolic function in nonischemic cardiomyopathy patients with heart failure after chronic treatment with carvedilol.
Chen L; Meyers D; Javorsky G; Burstow D; Lolekha P; Lucas M; Semmler AB; Savarimuthu SM; Fong KM; Yang IA; Atherton J; Galbraith AJ; Parsonage WA; Molenaar P
Pharmacogenet Genomics; 2007 Nov; 17(11):941-9. PubMed ID: 18075464
[TBL] [Abstract][Full Text] [Related]
19. Treatment with selumetinib preserves cardiac function and improves survival in cardiomyopathy caused by mutation in the lamin A/C gene.
Muchir A; Reilly SA; Wu W; Iwata S; Homma S; Bonne G; Worman HJ
Cardiovasc Res; 2012 Feb; 93(2):311-9. PubMed ID: 22068161
[TBL] [Abstract][Full Text] [Related]
20. Functional consequences of an LMNA mutation associated with a new cardiac and non-cardiac phenotype.
Charniot JC; Pascal C; Bouchier C; Sébillon P; Salama J; Duboscq-Bidot L; Peuchmaurd M; Desnos M; Artigou JY; Komajda M
Hum Mutat; 2003 May; 21(5):473-81. PubMed ID: 12673789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
